About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?
Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...